Semanteon Capital Management »

Alnylam Pharmaceuticals shares owned by Semanteon Capital Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Semanteon Capital Management from 13F filings

Historical chart of Semanteon Capital Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Semanteon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Semanteon Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $562k 1.2k 456.00
2024-09-30 $759k 2.8k 275.03
2023-12-31 $308k 1.6k 191.41

More positions owned by Semanteon Capital Management

Bloom Energy Corp Com Cl A (BE)
Helen Of Troy (HELE)
Vishay Intertechnology (VSH)
Confluent Class A Com (CFLT)
Apollo Global Mgmt (APO)
V.F. Corporation (VFC)
Impinj (PI)
Pure Storage Cl A (PSTG)
OSI Systems (OSIS)
Apa Corporation (APA)
Western Digital (WDC)
Hecla Mining Company (HL)
CTS Corporation (CTS)
Nov (NOV)
Robert Half International (RHI)

View all positions for Semanteon Capital Management

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals